
Koch Industries announced that it has closed on the acquisition of Infor, announced in February. The company never officially announced the purchase price, but sources indicated that it was close to US$13 billion, putting it in line to be one of the top 10 enterprise acquisitions this year.
The company will remain an independent subsidiary of Koch, which tends to deal more in manufacturing than software. The goal is to use the resources of Koch to continue to build out the Infor product family with a focus on industry-specific solutions, according to the company.
At the time of the deal in February, CEO Kevin Samuelson certainly saw the potential of having a company with the financial resources of Koch backing his organization.
“As a subsidiary of a $110 billion+ revenue company that re-invests 90% of earnings back into its businesses, we will be in the unique position to drive digital transformation in the markets we serve,” Samuelson said.
As the company pointed out, Infor is helping customers move to the cloud, even in industries like manufacturing, distribution, and finance that might otherwise be stuck on legacy systems. This transition to the cloud is becoming even more pressing as companies deal with the COVID-19 crisis and are forced to find creative ways to keep their businesses going, even when many employees can’t come into the office. Having access to applications in the cloud certainly helps ease that burden.
The company counts some of the largest organizations in the world as customers, including 17 of the top 20 global banks, 9 of the 10 largest global hotel brands, and 7 of the top 10 global luxury brands.
Full Content:
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas